Women who report significant antibiotic use in midlife are more likely to experience cognitive decline in later life, perhaps through gut microbiome changes, in study of almost 15,000 U.S. nurses
Credit: Volodymyr Hryshchenko, Unsplash, CC0 (https://creativecommons.org/publicdomain/zero/1.0/)
Women who report significant antibiotic use in midlife are more likely to experience cognitive decline in later life, perhaps through gut microbiome changes, in study of almost 15,000 U.S. nurses
###
Article URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0264649
Article Title: Association of midlife antibiotic use with subsequent cognitive function in women
Author Countries: U.S.A.
Funding: This work was supported by U.S. National Institutes of Health (NIH) grants [U01 CA176726; K23 DK125838; U01 AG062682; RF1 AG067744], Stuart and Suzanne Steele MGH Research Scholar Award to Dr Chan. The content is solely the responsibility of the authors. The funders had no role in study design, data collection, analysis, decision to publish, or manuscript preparation.
Journal
PLoS ONE
DOI
10.1371/journal.pone.0264649
Article Title
Association of midlife antibiotic use with subsequent cognitive function in women
Article Publication Date
23-Mar-2022
COI Statement
The authors of this manuscript have read the journal’s policy and have the following competing interests: Dr. Chan served as a consultant for Bayer Pharma AG, Pfizer Inc., and Boehringer Ingelheim. Dr. Kochar served on an advisory board to Pfizer. This study was not funded by Bayer Pharma AG, Boehringer Ingelheim, or Pfizer Inc. No other conflict of interest exists. The other authors declare that they have no conflicts of interest.
